1,25 Dihydroxyvitamin D3 Activates Sphingomyelin Turnover in ROS17/2.8 Osteosarcoma Cells without Sphingolipid-Induced Changes in Cytosolic Ca2+
- 1 June 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 273 (1) , 95-100
- https://doi.org/10.1006/bbrc.2000.2905
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Bradykinin Increases Ceramide and Sphingosine Content in Human Fibroblasts: Possible Involvement of GlycosphingolipidsBiochemical and Biophysical Research Communications, 1996
- Effects of Sphingosine Derivatives on MC3T3-E1 Preosteoblasts: Psychosine Elicits Release of Calcium from Intracellular StoresBiochemical and Biophysical Research Communications, 1995
- Inhibitors of ER Ca2+-ATPase activity deplete the ATP- and thrombin-sensitive Ca2+ pool in UMR 106–01 osteosarcoma cellsJournal of Bone and Mineral Research, 1995
- Activation of the Sphingomyelin Signaling Pathway in Intact EL4 Cells and in a Cell-Free System By IL-1βScience, 1993
- Tumor Necrosis Factor-α Activates the Sphingomyelin Signal Transduction Pathway in a Cell-Free SystemScience, 1992
- Intracellular Calcium Release Mediated by Sphingosine Derivatives Generated in CellsScience, 1990
- Dexamethasone increases neutral sphingomyelinase activity and sphingosine levels in 3T3-L1 fibroblastsBiochemical and Biophysical Research Communications, 1990
- Signal transduction in the onset of terminal keratinocyte differentiation induced by 1 α, 25-dihydroxyvitamin D3: Role of protein kinase C translocationBiochemical and Biophysical Research Communications, 1989
- A model for receptor-regulated calcium entryCell Calcium, 1986
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959